E L White1, W R Chao, L J Ross
1Department of Biochemistry, Southern Research Institute, Birmingham, Alabama 35205, USA. white@sri.org
Michellamines A, B, and C show antiviral effects by inhibiting HIV reverse transcriptase, cellular fusion, and protein kinase C (PKC). These compounds bind to the PKC kinase domain, suggesting a new therapeutic avenue.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: